Kite raises $127.5 million, jumps in trading debut

Cancer immunotherapy play Kite Pharma Inc. (NASDAQ:KITE) jumped $12 (71%) to $29 on its first day of trading after raising $127.5 million through the sale of 7.5 million shares at $17 in an IPO. The price values Kite at $632.4 million. On Thursday, Kite said it planned to sell 7.5 million shares at $15-$16. Jefferies; Credit Suisse; Cowen; and Stifel are underwriters. ...